Optimal Vasodilators in Microsurgery and Their Effects on Blood Vessels
Misato Ueda,Tadashi Nomura,Hiroto Terashi,Shunsuke Sakakibara
DOI: https://doi.org/10.1055/a-2483-5634
2024-12-18
Journal of Reconstructive Microsurgery
Abstract:Dear Editor, We read with great interest a recently published article in your esteemed journal, titled "Lasting Effects of Surgically Used Topical Vasodilators on DIEP Artery Vascular Function."[1] The discussion of the effects of papaverine, lidocaine, and verapamil on the vasodilation of human deep inferior epigastric perforator artery beyond the duration of local drug administration is truly compelling. However, the following points warrant further discussion. This study suggests that agents other than lidocaine have a persistent negative impact on arterial vasodilation, even after their acute effects subside. This raises the question of the effects of these agents on the vascular tissue itself. In clinical microsurgery, 1 or 2% lidocaines are commonly used.[2] [3] Our research group observed that high concentrations of lidocaine induced a potent relaxation effect without subsequent recontraction, leading us to suspect that irreversible tissue damage may have occurred due to the drug.[4] If the administered drug exhibits cytotoxicity, the potential damage to endothelial and smooth muscle cells must be considered. Irreversible damage to the smooth muscle cells may result in prolonged vasodilation, which may be beneficial for flap perfusion. However, damage to the endothelial cells can disrupt their antithrombotic properties, potentially leading to vascular occlusion. In our study, we quantified the vasorelaxant effects of various drugs and assessed their cytotoxicity.[5] We found that lidocaine and papaverine hydrochloride exhibited strong antispasmodic effects and demonstrated cytotoxicity in both endothelial and smooth muscle cells. The experimental setup (isometric tension system) used by the authors appeared to be similar to the wire-myograph system that we employed. In such experiments, drugs permeate the vasculature through both luminal and cross-sectional surfaces. Thus, it is important to consider both the pharmacological effects and cytotoxicity when conducting such experiments. The authors demonstrated persistent negative effects and lack of response to vasospasm-relieving drugs after prolonged exposure. However, as we have shown, cytotoxicity manifests rapidly, suggesting that prolonged exposure of the luminal surface to these drugs, even for durations in the order of minutes, should be avoided. Therefore, it is crucial to determine the optimal exposure time that balances the period required for vasospasm relief with the onset of cytotoxic effects. In our experiments, phentolamine—a potent α-blocker used in pheochromocytoma surgery—exhibited low cytotoxicity and a strong antispasmodic effect comparable to lidocaine.[5] Although phentolamine is an inexpensive alternative, its off-label use requires clinical trials, which may be prohibitively expensive, especially in Japan. Given the high cost of conducting clinical trials, particularly for affordable drugs, such as phentolamine, pursuing expanded indications is often impractical. Lidocaine, on the other hand, not only provides antispasmodic effects but also contributes to pain management when locally applied in the surgical field. Thus, lidocaine may be the preferred choice in practical terms. Nevertheless, further investigation into the optimal concentration, exposure time, and potential adverse effects is warranted to ensure its safe and effective use. Received: 16 September 2024 Accepted: 11 November 2024 Article published online: 17 December 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
surgery